Progenics Announces Will Host Call Related to FDA Appeal Response Related to RELISTOR sNDA

Progenics Pharmaceuticals, Inc.

chief executive officer Mark Baker will comment on the FDA's Relistor^® Appeal Response in a conference call this morning, Monday, July 14, at 8:30 a.m. Eastern Time. More information concerning the Appeal Response is available in the joint press release issued this morning with the Company's collaboration partner, Salix Pharmaceuticals

. To participate in the call, please dial (877) 250-8889 (domestic) or (720) 545-0001 (international) and reference conference ID 74147589. A live webcast will be available on the Media Center of the Progenics website, www.progenics.com, and a replay will be available there for two weeks.